TrioTree Technologies, a leading healthcare IT solutions provider, has reached a major technological breakthrough with the successful deployment of its AI and NLP-powered voice-to-structured-data system across partner clinics. This cutting-edge...
.jpeg){kind=spacer}
AstraZeneca Pharma India has obtained an approval by the Central Drugs Standard Control Organisation (CDSCO) to import and market Durvalumab solution for infusion with an expanded indication in India.
.png)
The US Food and Drug Administration (FDA) has granted new approval for Bayer’s finerenone (Kerendia) with a new indication to treat adults with heart failure and a left ventricular ejection fraction (LVEF) of 40% or higher...
On Tuesday, Aurobindo Pharma announced that it will produce and distribute cabotegravir, a long-acting injectable HIV therapy, in 133 nations. According to a statement from the firm, the Hyderabad-based pharmaceutical company has been chosen as on
The Top 10 Women Disruptors in Asia from the Pharmaceutical Industry who are creating new pathways for innovation and impact. These inspiring leaders are from various countries throughout the continent, imparting diverse views of the future of
AstraZeneca reported encouraging top-line results from the Phase III BaxHTN trial, demonstrating baxdrostat's statistically significant and clinically significant decrease in mean seated systolic blood pressure
Baxdrostat at two doses (2 mg and 1 mg) showed a statistically significant and clinically relevant reduction in mean sitting systolic blood pressure (SBP) at 12 weeks when compared with placebo, according to positive high-level data from the BaxHTN
The World Health Organization (WHO) has taken a significant step forward by endorsing Gilead's lenacapavir, an injectable drug twice-yearly, as a preventive measure to protect against HIV. The WHO confirmed this recommendation on Monday morning...
Aayush Wellness, a leading player in the Ayurvedic and wellness segments, has announced a strategic expansion of its nutraceutical product lines in order to bolster its presence into India's robust and emerging health and wellness sector...
Sun Pharmaceutical Industries Ltd. has announced the availability of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S. to treat severe alopecia areata, a severe autoimmune disorder that unpredictably causes hair loss in adult patients.
.jpg)
, CDSCO.jpg)